STRATA Skin Sciences (SSKN) Cash from Financing Activities (2010 - 2025)

STRATA Skin Sciences has disclosed Cash from Financing Activities across 15 years of filings, most recently posting $1.4 million for Q4 2025.

• Cash from Financing Activities for Q4 2025 came in at $1.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $3.6 million (up 85.92% YoY), and the FY2025 annual result was $3.6 million, up 85.92% from the prior year.
• Cash from Financing Activities came in at $1.4 million for Q4 2025 at STRATA Skin Sciences, down from $2.2 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $7.0 million in Q2 2023 to a low of -$500000.0 in Q4 2022.
• The 5-year median for Cash from Financing Activities is $739500.0 (2021), against an average of $1.5 million.
• Across the five-year window, Cash from Financing Activities soared 1968.27% in 2024 and gained 12.82% in 2025, its largest moves.
• STRATA Skin Sciences' Cash from Financing Activities stood at $92000.0 in 2021, then sank by 643.48% to -$500000.0 in 2022, then soared by 79.2% to -$104000.0 in 2023, then jumped by 1968.27% to $1.9 million in 2024, then declined by 28.62% to $1.4 million in 2025.
• The last three Cash from Financing Activities figures came in at $1.4 million (Q4 2025), $2.2 million (Q3 2025), and $1.9 million (Q3 2024), per Business Quant data.